/PRNewswire/ GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology.
HERCULES, Calif. (BUSINESS WIRE) Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023.First-quarter 2023 net sales were $676.8 million, a decrease of 3.3 percent compa.
Operator: Good afternoon. Thank you for attending the Bio-Rad First Quarter 2023 Earnings Conference Call. My name is Matt, and I ll be your moderator for today s call.